Related Experiment Video
Updated: Jun 5, 2025

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
Molecular mechanisms and potential interventions during aging-associated sarcopenia
Xiaoqin Luo1, Jin Wang1, Qingqing Ju1
1College of Life Science, Liaoning University, Shenyang 110036, China.
Abstract:
Sarcopenia, a common condition observed in the elderly, presenting a significant public health challenge due to its high prevalence, insidious onset and diverse systemic effects. Despite ongoing research, the precise etiology of sarcopenia remains elusive. Aging-related processes, which included inflammation, oxidative stress, compromised mitochondrial function and apoptosis, have been implicated in its development. Notably, effective pharmacological treatments for sarcopenia are currently lacking, highlighting the necessity for a deeper understanding of its pathogenesis and causative factors to enable proactive interventions. This article is aimed to provide an extensive overview of the pathogenesis of sarcopenia, along with a summary of current treatment and prevention strategies.
Insights
Sarcopenia, muscle loss in aging, lacks clear causes and treatments. Understanding its aging-related mechanisms like inflammation and oxidative stress is key for developing interventions.
Area of Science:
- Gerontology
- Muscle physiology
- Aging research
Background:
- Sarcopenia is a prevalent condition in the elderly, posing a significant public health concern.
- Its etiology is complex and not fully understood, involving multiple aging-related processes.
- Current pharmacological treatments for sarcopenia are limited, necessitating further research.
Purpose of the Study:
- To provide a comprehensive overview of sarcopenia pathogenesis.
- To summarize current therapeutic and preventive strategies for sarcopenia.
- To highlight the need for deeper understanding to enable proactive interventions.
Main Methods:
- Literature review of aging-related processes implicated in sarcopenia.
- Analysis of current research on sarcopenia etiology.
- Synthesis of existing treatment and prevention strategies.
Main Results:
- Aging processes such as inflammation, oxidative stress, mitochondrial dysfunction, and apoptosis contribute to sarcopenia.
- The precise causative factors of sarcopenia remain under investigation.
- Effective pharmacological interventions are currently unavailable.
Conclusions:
- A deeper understanding of sarcopenia pathogenesis is crucial for developing effective treatments.
- Targeting aging-related pathways may offer potential therapeutic avenues.
- Proactive strategies for sarcopenia prevention and management are needed.
Related Concept Videos
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
The Effect of Aging on Tissues
Mitochondria
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

